Related Experiment Videos
[Transperitoneal resorption in acute and chronic peritonitis (author's transl)]
Langenbecks Archiv Fur Chirurgie
|October 16, 1978
Summary
A proteinase inhibitor reduced the absorption of protein-bound antibiotics in rats with peritonitis. This finding suggests potential therapeutic applications for managing protein-bound toxins during peritoneal inflammation.
Area of Science:
- Pharmacology
- Physiology
- Toxicology
Context:
- Peritonitis, an inflammation of the peritoneum, can affect drug absorption.
- Protein-bound substances and proteolytic enzymes play a role in peritoneal function.
- Aminoglycoside antibiotics are commonly used, and their absorption can be influenced by peritoneal conditions.
Purpose:
- To investigate the effect of a proteinase inhibitor on peritoneal resorption function in rats with acute and chronic peritonitis.
- To measure serum concentrations of an aminoglycoside antibiotic after co-administration with a proteinase inhibitor.
- To explore the relationship between molecule size, protein binding, and proteolytic enzymes in peritoneal absorption.
Summary:
- This study examined two forms of peritonitis in Wistar rats, comparing acute and chronic inflammation against a control group.
- Animals received an aminoglycoside antibiotic and a proteinase inhibitor. Serum antibiotic concentrations were measured at 30, 60, and 90 minutes.
- Results indicated that in clinical dosages, the proteinase inhibitor decreased the resorption of protein-bound aminoglycoside antibiotics, with no effect observed in healthy controls.
Impact:
- The findings suggest that proteinase inhibitors can retard the absorption of protein-bound substances, including toxins, in the peritoneal cavity.
- This has potential clinical relevance for managing conditions involving peritoneal inflammation and the absorption of protein-bound toxins.
- Understanding these interactions is crucial for optimizing drug delivery and therapeutic outcomes in peritonitis patients.